Farida Mébarki

1.2k total citations
19 papers, 800 citations indexed

About

Farida Mébarki is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cell Biology. According to data from OpenAlex, Farida Mébarki has authored 19 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 6 papers in Cell Biology. Recurrent topics in Farida Mébarki's work include Sexual Differentiation and Disorders (13 papers), Hormonal and reproductive studies (9 papers) and Hormonal Regulation and Hypertension (9 papers). Farida Mébarki is often cited by papers focused on Sexual Differentiation and Disorders (13 papers), Hormonal and reproductive studies (9 papers) and Hormonal Regulation and Hypertension (9 papers). Farida Mébarki collaborates with scholars based in France, Canada and United States. Farida Mébarki's co-authors include Yves Morel, Jacques Simard, Maguelone G. Forest, Éric Rhéaume, Jean‐Louis Chaussain, Fernand Labrie, M. Zachmann, Maria I. New, I Mowszowicz and Rocío Sánchez and has published in prestigious journals such as Nature Genetics, The Journal of Clinical Endocrinology & Metabolism and Biochemistry.

In The Last Decade

Farida Mébarki

18 papers receiving 769 citations

Peers

Farida Mébarki
Li‐Qun Cai United States
Y. Lachance Canada
C C Moore United States
Van Luu The Canada
Koichiro Isurugi Japan
Trent R. Clarke United States
Stathis Nikolaropoulos Greece
Marina Rodríguez Spain
Stella Campo Argentina
C. Auclair Canada
Li‐Qun Cai United States
Farida Mébarki
Citations per year, relative to Farida Mébarki Farida Mébarki (= 1×) peers Li‐Qun Cai

Countries citing papers authored by Farida Mébarki

Since Specialization
Citations

This map shows the geographic impact of Farida Mébarki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farida Mébarki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farida Mébarki more than expected).

Fields of papers citing papers by Farida Mébarki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farida Mébarki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farida Mébarki. The network helps show where Farida Mébarki may publish in the future.

Co-authorship network of co-authors of Farida Mébarki

This figure shows the co-authorship network connecting the top 25 collaborators of Farida Mébarki. A scholar is included among the top collaborators of Farida Mébarki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farida Mébarki. Farida Mébarki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pujić, Petar, Alexander Bolotin, Pascale Fournier, et al.. (2015). Genome Sequence of the Atypical Symbiotic Frankia R43 Strain, a Nitrogen-Fixing and Hydrogen-Producing Actinobacterium. Genome Announcements. 3(6). 20 indexed citations
2.
Mébarki, Farida, et al.. (2014). Les complications chirurgicales du cancer de la thyroïde : a propos de 66 cas. Annales françaises d Oto-rhino-laryngologie et de Pathologie Cervico-faciale. 131(4). A124–A124. 1 indexed citations
3.
Quigley, Charmian A., Jiann-an Tan, Bin He, et al.. (2004). Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH2- and carboxyl-terminal interaction. Mechanisms of Ageing and Development. 125(10-11). 683–695. 40 indexed citations
4.
Ricketts, Marie‐Louise, Véronique Tardy, Marc Desrochers, et al.. (1999). New Insight into the Molecular Basis of 3β-Hydroxysteroid Dehydrogenase Deficiency: Identification of Eight Mutations in the HSD3B2 Gene in Eleven Patients from Seven New Families and Comparison of the Functional Properties of Twenty-Five Mutant Enzymes1. The Journal of Clinical Endocrinology & Metabolism. 84(12). 4410–4425. 75 indexed citations
5.
Morel, Yves, Farida Mébarki, Éric Rhéaume, et al.. (1997). Structure-function relationships of 3β-hydroxysteroid dehydrogenase: Contribution made by the molecular genetics of 3β-hydroxysteroid dehydrogenase deficiency. Steroids. 62(1). 176–184. 49 indexed citations
6.
Simard, Jacques, Francine Durocher, Farida Mébarki, et al.. (1996). Molecular biology and genetics of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase gene family. Journal of Endocrinology. 150. 41 indexed citations
7.
Rodien, Patrice, Farida Mébarki, I Mowszowicz, et al.. (1996). Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene.. The Journal of Clinical Endocrinology & Metabolism. 81(8). 2994–2998. 59 indexed citations
8.
Simard, Jacques, Francine Durocher, Farida Mébarki, et al.. (1996). Molecular biology and genetics of the 3 beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.. PubMed. 150 Suppl. S189–207. 62 indexed citations
9.
10.
Nicolas, Brigitte, et al.. (1995). Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP. The Journal of Steroid Biochemistry and Molecular Biology. 55(1). 67–76. 33 indexed citations
11.
Mébarki, Farida. (1995). Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene. The Journal of Clinical Endocrinology & Metabolism. 80(7). 2127–2134. 9 indexed citations
12.
Simard, Jacques, Francine Durocher, Éric Rhéaume, et al.. (1995). Structure-function relationships and molecular genetics of the 3β-hydroxysteroid dehydrogenase gene family. The Journal of Steroid Biochemistry and Molecular Biology. 55(5-6). 489–505. 19 indexed citations
13.
Simard, Jacques, et al.. (1995). Molecular basis of human 3β-hydroxysteroid dehydrogenase deficiency. The Journal of Steroid Biochemistry and Molecular Biology. 53(1-6). 127–138. 49 indexed citations
14.
Mébarki, Farida, Rocío Sánchez, Éric Rhéaume, et al.. (1995). Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene.. The Journal of Clinical Endocrinology & Metabolism. 80(7). 2127–2134. 24 indexed citations
15.
Mébarki, Farida, Maguelone G. Forest, & Nathalie Josso. (1994). Complete direct sequencing of the entire AR gene in 45 unrelated patients with androgen insensitivity syndrome: Mutations identified in 32 patients (18 novel mutations), no mutation detected in 13 other patients (29%). The American Journal of Human Genetics. 55. 4 indexed citations
16.
Mébarki, Farida, Éric Rhéaume, Nathalie Laflamme, et al.. (1994). Functional characterization of the novel L108W and P186L mutations detected in the type II 3β-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia. Human Molecular Genetics. 3(9). 1639–1645. 26 indexed citations
17.
Rey, Rodolfo A., Farida Mébarki, Maguelone G. Forest, et al.. (1994). Anti-müllerian hormone in children with androgen insensitivity.. The Journal of Clinical Endocrinology & Metabolism. 79(4). 960–964. 92 indexed citations
18.
Simard, Jacques, Yves Morel, Éric Rhéaume, et al.. (1993). MOLECULAR BASIS OF CONGENITAL ADRENAL HYPERPLASIA DUE TO 3β-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY. Pediatric Research. 33. S6–S6. 4 indexed citations
19.
Rhéaume, Éric, Jacques Simard, Yves Morel, et al.. (1992). Congenital adrenal hyperplasia due to point mutations in the type II 3β–hydroxysteroid dehydrogenase gene. Nature Genetics. 1(4). 239–245. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li‐Qun Cai Breakdown of academic impact, for papers by Y. Lachance Breakdown of academic impact, for papers by C C Moore Breakdown of academic impact, for papers by Van Luu The Breakdown of academic impact, for papers by Koichiro Isurugi Breakdown of academic impact, for papers by Trent R. Clarke Breakdown of academic impact, for papers by Stathis Nikolaropoulos Breakdown of academic impact, for papers by Marina Rodríguez Breakdown of academic impact, for papers by Stella Campo Breakdown of academic impact, for papers by C. Auclair
Rankless by CCL
2026